logo-ellex-site-lm-ophta-63be68c452e50795544101.png

SLT Laser | OCT Assisted Precision

ASTRAL® is a next-generation Selective Laser Trabeculoplasty (SLT) platform that combines advanced laser technology with real-time OCT imaging redefining glaucoma treatment. Designed to deliver precise, contact-free therapy, ASTRAL® streamlines every step of the clinical workflow while enhancing patient comfort and treatment confidence.

By integrating intelligent software, precise targeting, and high-resolution OCT imaging into a single ergonomic platform, ASTRAL® enables clinicians to perform fast, accurate, and reproducible SLT procedures for first-line glaucoma therapy. 

ASTRAL® sets a new standard for precision, efficiency and ease of use.

Key Features

  • SLT designed for first-line glaucoma therapy, with OCT-assisted targeting of the trabecular meshwork resulting in precise, safe, and confluent treatment through the Scelra.
  • Contact-free, lens-free treatment eliminating the need for coupling gels, improving the patient experience and allowing vision to recover within minutes.
  • ASTRAL’s integrated OCT acquires 120 images (full eye), delivering a comprehensive view of the iridocorneal angle. Simply navigate around the eye and ASTRAL Intelligence displays the corresponding OCT for each potential treatment location.
  • Intelligent workflow streamlines setup and treatment, reducing active patient engagement to ~15 seconds per eye compared to >10 minutes with traditional SLT.

3 reasons to choose ASTRAL®

See the target. Treat with confidence.

ASTRAL combines Selective Laser Trabeculoplasty (SLT) with real-time OCT imaging, enabling precise visualization and targeting of the trabecular meshwork.

Intelligent targeting delivering accurate, confluent treatment while enhancing safety and reducing clinician variability.

oct guided

A gentle treatment designed around patient comfort

ASTRAL eliminates the need for contact lenses and coupling gels, providing a completely non-contact treatment experience

Patients benefit from improved comfort, no sustained blurred vision, and the ability to return to their daily activities within minutes.

patient experience

Smarter Work flow. Faster treatments.

From targeting to treatment  ASTRAL improves clinical workflow by significantly reducing preparation and post-treatment time. Intelligent software assists you through the critical steps of alignment, focusing, OCT acquisition, targeting and treatment. 

Active patient engagement is reduced to approximately 15 seconds per eye, improving efficiency without compromising precision.

intelligent software
astral interface

Designed for clinicians. 
Optimized for every procedure.

ASTRAL's intuitive software transforms a complex and physically demanding procedure into a streamlined workflow with minimal manual requirements.

OCT visualization, precise targeting, and assisted treatment help clinicians achieve efficacious reproducible results without the need for contact lenses or coupling gels.

Clinical advantages of ASTRAL®


ASTRAL® is a trademark of Ellex Medical Pty Ltd, Ellex Medical Pty Ltd, member
of Lumibird Medical Division. All rights reserved.


BIBLIOGRAPHY

1- For publicly available study information and summary results, please refer to ClinicalTrials.gov.
Reference: ClinicalTrials.gov. Identifier: NCT06833060. Exploratory Clinical Study of a Laser-OCT Integrated System With Eye Tracking to Treat Glaucoma and OHT With Transscleral Selective Laser Trabeculoplasty Technology: A Pilot Study (TSLT-001-2023). Available at: https://clinicaltrials.gov/study/NCT06833060
2- Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. LiGHT trial: 6-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology. 2022;16:S0161-6420(22)00732-1

Download brochure
Contact Us